Autism Spectrum Disorder (ASD) & Special Needs

Metabolic Connection

A pattern-based urine metabolite assessment that may
help contextualize gut, mitochondrial, nutrient, and
detoxification-related physiology in complex 
neurodevelopmental presentations.

Children with ASD and related special needs presentations often have overlapping gastrointestinal, mitochondrial, nutrient, and redox-related physiology that may not be apparent from symptoms alone.[1,2,8,13,19] 

The Organic Acids Test (OAT) is a pattern-based assessment looking at imbalances that can support clinical reasoning by identifying metabolite trends associated in the literature with dysbiosis, altered energy metabolism, and cofactor insufficiency.[1,4,7,14]

Explore the Organic Acids Test

When to Consider OAT

What OAT Measures

Clinical Applications & Evidence Context

How OAT Supports Clinical Reasoning

How to Order the OAT

References

When to Consider Organic Acids Test (OAT)

Neurologic & Mental Health – Metabolic Connection1

GI complaints:Constipation, diarrhea, bloating, foul-smelling stool, or variable bowel patterns that may suggest microbial or fermentation-related imbalance [2,3,4,6]

Behavioral variability after foods or antimicrobials: Symptom shifts that may track with yeast, clostridia, or altered gut-brain signaling [4,5,6,7]

Energy or endurance concerns: Fatigue, poor stamina, regression after illness, or patterns consistent with impaired mitochondrial efficiency [1,8,9]

Nutrient insufficiency questions :Restricted eating, selective diets, or concern for functional B-vitamin, antioxidant, or cofactor need [17,18,19]

Redox or detoxification stress patterns: Clinical concern for low glutathione resilience, methylation burden, or oxidative stress-related vulnerability [13,14,15,16] 

Complex multisystem presentations: Children with overlapping sleep, attention, communication, sensory, and GI concerns where a broader metabolic snapshot may help organize next steps [1,7,10,11]

Analyte ClassWhat It ReflectsClinical Relevance
Microbial OvergrowthGut fermentation products from bacterial, yeast, and fungal activity; literature discusses clostridia-, Candida-, and Aspergillus-associated metabolites rather than a single external exposure source [2,4,5,6]May help contextualize dysbiosis-related metabolite output, gut-brain signaling, and neurotransmitter-related patterns observed in ASD literature [2,3,4,6]
Mitochondrial Health / Energy MarkersPhysiologic demand, illness stress, and metabolic inefficiency can shift pyruvate, lactate, citric acid cycle intermediates, and beta-oxidation markers; these are endogenous functional markers rather than direct exposure markers. [1,8,9]May reflect altered energy production, TCA cycle stress, or fatty acid oxidation inefficiency associated in the literature with ASD subgroups.[1,8,9]
Neurotransmitter MetabolitesDownstream urinary metabolites of catecholamine and serotonin turnover, shaped by host metabolism and potentially by gut-derived metabolites such as HPHPA. [5,10,11]Can support pattern recognition around dopamine, norepinephrine, serotonin, and kynurenine pathway balance and cofactor needs.[5,10,11,12]
Methylation / Detoxification MarkersMethyl donor and transsulfuration pathway intermediates influenced by B12, folate-related metabolism, glutathione demand, and redox stress. [13,14,15]May help contextualize methylation capacity, glutathione synthesis resilience, and redox burden discussed in ASD literature. [13,14,15,16]
Nutrient needsFunctional signals related to B2, B5, B6, B12, vitamin C, and CoQ10-dependent pathways rather than direct dietary intake. [17,18,19]Can support clinical reasoning around cofactor need when interpreted with imbalances assessed on the OAT. [17,18,19]
Toxic ExposureMarkers associated with fungal/mycotoxin-related patterns, mineral binding effects, or broader toxicant stress; OAT does not directly quantify toxicants or mycotoxins. [1,5,17]
May help contextualize environmental burden hypotheses when paired with history and other testing, especially when TCA and microbial patterns converge. [1,5,17]

ConditionClinical Encapsulation
Autism spectrum disorderIn urinary organic acid patterns across microbial, mitochondrial, nutrient, and redox domains have been reported in the ASD research literature (case-control, review, and metabolomic studies); these finds are exploratory and not diagnostic. [1,7,9,19]
Gut dysbiosis / microbial overgrowthClostridia-, yeast-, and broader microbiota-derived metabolites have been linked with altered gut-brain signaling and neurobehavioral features in ASD literature, supporting hypothesis generation around intestinal contributors. [2,3,4,5,6]
Mitochondrial dysfunction patternsSystematic reviews and urinary organic acid studies describe associations between ASD and altered pyruvate, lactate, TCA intermediates, and beta-oxidation markers consistent with impaired energy metabolism. [1,8,9]
Neurotransmitter imbalance patternsHPHPA-related dopamine-beta-hydroxylase inhibition and altered kynurenine pathway balance provide mechanistic models for how urinary metabolites may align with catecholamine and neuroinflammatory physiology. [5,10,11,12]
Methylation / transsulfuration stressMethylation cycle and glutathione pathway differences reported in ASD cohorts provide context for interpreting pyroglutamate, methylmalonic, and related OAT markers as functional signals [13,14,15,16]
Functional nutrient insufficiencyB-vitamin and antioxidant pathway disruptions reported in ASD may help explain imbalances seen when intake, absorption, and metabolic demand are clinically relevant. [17,18,19]
Oxalate-related burdenUrinary and plasma oxalate elevations have been reported in ASD cohorts, suggesting a possible contributory pattern in selected patients when interpreted alongside GI and nutrient context. [20]

Pattern recognition: 

OAT can help organize findings across microbial, mitochondrial, neurotransmitter, nutrient, and redox domains rather than relying on a single marker. [1,7,17] 

Subgroup context: 

Published literature suggests physiologic heterogeneity within ASD, so metabolite patterns may help identify which mechanisms are most relevant for a given patient presentation. [1,8,11,19] 

Follow-up planning: 

Results may inform whether stool, nutrient, toxicant, mitochondrial, or broader clinical history review should be prioritized next. [2,5,13,17] 

Response monitoring: 

Repeating a pattern-based metabolite assessment can support longitudinal clinical reasoning when dietary, antimicrobial, nutrient, or environmental interventions are being evaluated. [7,9,16] 

How to Order

Neurologic & Mental Health – Metabolic Connection1

To order the Organic Acids Test (OAT), register for a portal account. Specimen collection kits and requisition forms are available through your account portal. For clinical support or interpretation questions, contact our clinical education team.

Order the OAT

Explore Other Autism Spectrum Disorder (ASD) & Special Needs Lenses:

Exposure-Oriented
Connection
Metabolic
Connection
Gut-Brain
Connection
Food-Related
Connection
Download | Printable PDF

This webpage is intended for licensed healthcare professionals and is for informational and educational purposes only. The test results are not intended to diagnose, treat, cure, or prevent disease. All clinical interpretation should be done by a qualified healthcare professional in the context of the individual patient. Statements regarding associations between health symptoms and conditions do not constitute diagnostic claims.

References

  1. Frye RE, et al. Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis. 2024. PMID: 38703861. 
  2. Sanctuary MR, et al. The gut microbiota and dysbiosis in autism spectrum disorders. 2018. PMC6855251. 
  3. Mangiola F, et al. Autism spectrum disorders and the gut microbiota. 2019. PMC6471505. 
  4. Fattorusso A, et al. The impact of gut microbiota-derived metabolites in autism spectrum disorder. 2021. PMC8470471. 
  5. Shaw W. Inhibition of the beta-oxidation pathway of fatty acids and Clostridia bacteria in autism. 2023. PMC10289112. 
  6. Ding HT, et al. Clostridium bacteria and autism spectrum conditions: A systematic review and meta-analysis. 2018. PMC6024569. 
  7. Hao Y, et al. Urine organic acids as potential biomarkers for autism spectrum disorders. 2019. PMC6502994. 
  8. Siddiqui MF, et al. Mitochondrial dysfunction in autism spectrum disorders. 2016. PMC5137782. 
  9. Kaucka K, Zapliska A. Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. 2011. PMID: 21300048. 
  10. Frye RE, Rossignol DA. Examining autism spectrum disorders by biomarkers. 2012. PMC3672055. 
  11. Carpita B, et al. Does the kynurenine pathway play a pathogenic role in autism spectrum disorder? 2024. PMC11387593. 
  12. Mottron L, et al. Relationships between brain activity, tryptophan-related metabolites and autism spectrum disorder. 2025. DOI: 10.1038/s41467-025-58459-1. 
  13. Reed MC, et al. Mathematical modeling of the methionine cycle and transsulfuration pathway in autism spectrum disorder. 2016. PMC5293619. 
  14. James SJ, et al. Differential one-carbon metabolites among children with autism spectrum disorder. 2024. DOI: 10.1016/j.tjnut.2024.09.019. 
  15. James SJ, et al. One carbon metabolism disturbances and the C677T MTHFR variant in autism. 2008. PMC4496129. 
  16. Kern JK, et al. A clinical trial of glutathione supplementation in autism spectrum disorders. 2011. PMC3628138. 
  17. Frye RE. The biochemistry of autism. 2024. DOI: 10.5772/intechopen.1006869. 
  18. Cascavita L, et al. Vitamin B12 and autism spectrum disorder: A review. 2025. PMID: 40218978. 
  19. Chauhan A, et al. Modifiable nutritional biomarkers in autism spectrum disorder. 2025. PMC12072606. 
  20. Konstantynowicz J, et al. A potential pathogenic role of oxalate in autism. 2012. PMID: 21911305.